Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Microbot Medical ( (MBOT) ) has provided an announcement.
On June 10, 2025, Microbot Medical Inc. held its Annual Meeting of Stockholders, where several key proposals were approved, including an increase in authorized shares of common stock to 120,000,000 and the election of Class I Directors. The approval of these proposals enables the company to enhance its capital structure and maintain compliance with Nasdaq listing rules, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (MBOT) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Microbot Medical stock, see the MBOT Stock Forecast page.
More about Microbot Medical
Microbot Medical Inc. operates in the medical technology industry, focusing on the development and commercialization of innovative robotic medical devices.
Average Trading Volume: 2,569,077
Technical Sentiment Signal: Buy
Current Market Cap: $94.58M
Learn more about MBOT stock on TipRanks’ Stock Analysis page.